U.S. Markets closed

Becton, Dickinson and Company (BDX)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
199.31-2.08 (-1.03%)
At close: 4:01PM EDT

199.31 0.00 (0.00%)
After hours: 6:44PM EDT

People also watch
Full screen
Previous Close201.39
Bid0.00 x 0
Ask0.00 x 0
Day's Range199.31 - 202.27
52 Week Range161.29 - 206.63
Avg. Volume1,370,743
Market Cap45.36B
PE Ratio (TTM)33.10
Earnings DateN/A
Dividend & Yield2.92 (1.45%)
Ex-Dividend Date2017-09-07
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters48 minutes ago

    Becton Dickinson blood tubes not linked to inaccurate lead results -FDA

    Blood collection tubes made by Becton Dickinson & Co that were used in conjunction with Magellan Diagnostics' lead-testing devices were not linked to the cause of inaccurate results of lead levels, the U.S. Food and Drug Administration said on Thursday. The FDA in May had warned that Magellan's LeadCare test systems performed on blood samples might provide inaccurate results. Prior to that, Magellan, a unit of Meridian Bioscience Inc , had said that inaccurate blood test results could potentially be related to a change in the composition of the tops of certain blood collection tubes made by Becton Dickinson.

  • Market Realist2 days ago

    How Varian Is Harnessing Proton Therapy Market Opportunities

    The proton therapy market is a highly lucrative opportunity area for Varian Medical Systems (VAR). Proton therapy uses protons for treating cancer instead of X-rays. According to a Medgadget report,…